4-((3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-3-(((2R,4S,5S,6R)-4-hydroxy-5-(((2S,4S,5S,6R)-4-hydroxy-5-(((2S,4S,5S,6R)-4-hydroxy-5-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one;(3?,5?,12?)-3-[(O-2,6-Dideoxy-4-O-methyl-?-D-ribo-hexopyranosyl-(14)-O-2,6-dideoxy-?-D-ribo-hexopyranosyl-(14)-2,6-dideoxy-?-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide; 4'''-Methyldigoxin; 4'''-O-Methyldigoxin; Lanirapid; Lanitop
b-Methyldigoxin is a fully characterized chemical compound used as a reference standard of API Digoxin. The standard offered is compliant with regulatory guidelines. b-Methyldigoxin is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 30685-43-9
